Found: 6
Select item for more details and to access through your institution.
Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 3, p. 412, doi. 10.1111/apt.14426
- By:
- Publication type:
- Article
Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 150, doi. 10.1111/apt.13837
- By:
- Publication type:
- Article
Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 7, p. 728, doi. 10.1111/apt.13748
- By:
- Publication type:
- Article
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.
- Published in:
- Haemophilia, 2011, v. 17, n. 1, p. 103, doi. 10.1111/j.1365-2516.2010.02366.x
- By:
- Publication type:
- Article
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.
- Published in:
- Journal of Viral Hepatitis, 2013, v. 20, n. 8, p. 524, doi. 10.1111/jvh.12074
- By:
- Publication type:
- Article
Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings.
- Published in:
- Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 691, doi. 10.1111/jvh.12375
- By:
- Publication type:
- Article